Department of Social Epidemiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, California.
JAMA Netw Open. 2023 Mar 1;6(3):e235174. doi: 10.1001/jamanetworkopen.2023.5174.
Previous studies have shown that individuals who regularly walk, particularly 8000 daily steps or more, experience lower mortality. However, little is known about the health benefits of walking intensively only a few days a week.
To evaluate the dose-response association between the number of days an individual takes 8000 steps or more and mortality among US adults.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study evaluated a representative sample of participants aged 20 years or older in the National Health and Nutrition Examination Surveys 2005-2006 who wore an accelerometer for 1 week and their mortality data through December 31, 2019. Data were analyzed from April 1, 2022, to January 31, 2023.
Participants were grouped by the number of days per week they took 8000 steps or more (0 days, 1-2 days, and 3-7 days).
Multivariable ordinary least squares regression models were used to estimate adjusted risk differences (aRDs) for all-cause and cardiovascular mortality during the 10-year follow-up, adjusting for potential confounders (eg, age, sex, race and ethnicity, insurance status, marital status, smoking, comorbidities, and average daily step counts).
Among 3101 participants (mean [SD] age, 50.5 [18.4] years; 1583 [51.0%] women and 1518 [49.0%] men; 666 [21.5%] Black, 734 [23.7%] Hispanic, 1579 [50.9%] White, and 122 [3.9%] other race and ethnicity), 632 (20.4%) did not take 8000 steps or more any day of the week, 532 (17.2%) took 8000 steps or more 1 to 2 days per week, and 1937 (62.5%) took 8000 steps or more 3 to 7 days per week. Over the 10-year follow-up, all-cause and cardiovascular deaths occurred in 439 (14.2%) and 148 (5.3%) participants, respectively. Compared with participants who walked 8000 steps or more 0 days per week, all-cause mortality risk was lower among those who took 8000 steps or more 1 to 2 days per week (aRD, -14.9%; 95% CI -18.8% to -10.9%) and 3 to 7 days per week (aRD, -16.5%; 95% CI, -20.4% to -12.5%). The dose-response association for both all-cause and cardiovascular mortality risk was curvilinear; the protective association plateaued at 3 days per week. Different thresholds for the number of daily steps between 6000 and 10 000 yielded similar results.
In this cohort study of US adults, the number of days per week taking 8000 steps or more was associated with a lower risk of all-cause and cardiovascular mortality in a curvilinear fashion. These findings suggest that individuals may receive substantial health benefits by walking just a couple days a week.
先前的研究表明,经常散步的人,尤其是每天走 8000 步或更多的人,死亡率较低。然而,对于每周只密集散步几天对健康的益处知之甚少。
评估美国成年人每周走 8000 步或更多天数与死亡率之间的剂量反应关联。
设计、地点和参与者:本队列研究评估了美国国家健康和营养检查调查 2005-2006 年期间佩戴加速度计一周的 20 岁及以上代表性参与者样本及其死亡率数据,直至 2019 年 12 月 31 日。数据分析于 2022 年 4 月 1 日至 2023 年 1 月 31 日进行。
参与者按每周走 8000 步或更多天数分组(0 天、1-2 天和 3-7 天)。
使用多变量普通最小二乘法回归模型,在 10 年随访期间估计全因和心血管死亡率的调整风险差异(aRD),调整了潜在混杂因素(例如,年龄、性别、种族和民族、保险状况、婚姻状况、吸烟、合并症和平均每日步数)。
在 3101 名参与者(平均[标准差]年龄,50.5[18.4]岁;1583[51.0%]名女性和 1518[49.0%]名男性;666[21.5%]名黑人、734[23.7%]名西班牙裔、1579[50.9%]名白人、122[3.9%]名其他种族和民族)中,632 名(20.4%)没有在一周中的任何一天走 8000 步或更多,532 名(17.2%)每周走 8000 步或更多 1-2 天,1937 名(62.5%)每周走 8000 步或更多 3-7 天。在 10 年随访期间,共有 439 名(14.2%)参与者发生全因死亡,148 名(5.3%)参与者发生心血管死亡。与每周走 8000 步或更多 0 天的参与者相比,每周走 8000 步或更多 1-2 天(aRD,-14.9%;95%CI,-18.8%至-10.9%)和 3-7 天(aRD,-16.5%;95%CI,-20.4%至-12.5%)的全因死亡率风险较低。全因和心血管死亡率风险的剂量反应关系呈曲线状;保护关联在每周 3 天左右达到平台期。不同的每日步数阈值(6000 步至 10000 步)之间产生了类似的结果。
在这项对美国成年人的队列研究中,每周走 8000 步或更多天数与全因和心血管死亡率呈曲线相关。这些发现表明,每周只散步几天就可以大大提高健康水平。